Surgical resection for bulky or recurrent axillary metastatic melanoma

Journal of Surgical Oncology

Volumn 105, Issue 1, 2012, Pages 21-25

  Shada, Amber L ^a   Walters, Dustin M ^a   Tierney, Shannon N ^b   Slingluff Jr , Craig L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

Author keywords

Lymphadenectomy; Recurrent; Resection; stage III; Stage IV; Symptomatic

Indexed keywords

INTERFERON; INTERLEUKIN 2; PACLITAXEL;

ADULT; AMBULATORY SURGERY; ARM WEAKNESS; ARTICLE; ASYMPTOMATIC DISEASE; AXILLA METASTASIS; BLEEDING; CANCER PAIN; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; JOINT LIMITATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; MALE; MELANOMA; MENTAL DISEASE; NEUROPATHIC PAIN; OVERALL SURVIVAL; PARESTHESIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; REOPERATION; SURGICAL INFECTION; SURGICAL TECHNIQUE; TUMOR GROWTH; TUMOR RECURRENCE;

AXILLA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 83555173304     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22058     Document Type: Article

References (25)

1. Hu S, Parmet Y, Allen G, et al.: Disparity in melanoma: A trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol 2009; 145: 1369-1374.
2. Bouwhuis MG, Suciu S, Testori A, et al.: Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: Prognostic significance of autoantibodies-EORTC 18991. J Clin Oncol 2010; 28: 2460-2466.
3. Essner R, Lee JH, Wanek LA, et al.: Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004; 139: 961-966 (discussion 966-7).
4. Tauceri F, Mura G, Roseano M, et al.: Surgery and adjuvant therapies in the treatment of stage IV melanoma: Our experience in 84 patients. Langenbecks Arch Surg 2009; 394: 1079-1084.
5. Hussussian CJ,: Surgical treatment of advanced melanoma. Clin Plast Surg 2010; 37: 161-168.
6. Martinez SR, Young SE,: A rational surgical approach to the treatment of distant melanoma metastases. Cancer Treat Rev 2008; 34: 614-620.
7. Ollila DW,: Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol 2006; 7: 919-924. (Pubitemid 44615951)
8. Lejeune FJ,: The impact of surgery on the course of melanoma. Recent Results Cancer Res 2002; 160: 151-157.
9. Balch CM, Gershenwald JE, Soong SJ, et al.: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
10. Sarnaik AA, Zager JS, Sondak VK,: Multidisciplinary management of special melanoma situations: Oligometastatic disease and bulky nodal sites. Curr Oncol Rep 2007; 9: 417-427. (Pubitemid 47377072)
11. Wong SL, Coit DG,: Role of surgery in patients with stage IV melanoma. Curr Opin Oncol 2004; 16: 155-160. (Pubitemid 38402530)
12. Kim JY, Ross MI, Butler CE,: Reconstruction following radical resection of recurrent metastatic axillary melanoma. Plast Reconstr Surg 2006; 117: 1576-1583. (Pubitemid 44324461)
13. van Akkooi AC, Bouwhuis MG, van Geel AN, et al.: Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 2007; 33: 102-108. (Pubitemid 46131880)
14. Serpell JW, Carne PW, Bailey M,: Radical lymph node dissection for melanoma. ANZ J Surg 2003; 73: 294-299. (Pubitemid 36649279)
15. Kretschmer L, Preusser KP,: Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma. Langenbecks Arch Surg 2001; 386: 418-425.
16. Balch CM, Soong SJ, Gershenwald JE, et al.: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634. (Pubitemid 32786275)
17. Calabro A, Singletary SE, Balch CM,: Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989; 124: 1051-1055. (Pubitemid 19231243)
18. Stevens G, Thompson JF, Firth I, et al.: Locally advanced melanoma: Results of postoperative hypofractionated radiation therapy. Cancer 2000; 88: 88-94. (Pubitemid 30027683)
19. Corry J, Smith JG, Bishop M, et al.: Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 1999; 44: 1065-1069. (Pubitemid 29342908)
20. Morris KT, Marquez CM, Holland JM, et al.: Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation. Ann Surg Oncol 2000; 7: 680-684.
21. Ballo MT, Ross MI, Cormier JN, et al.: Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 2006; 64: 106-113. (Pubitemid 41831216)
22. Ollila DW, Hsueh EC, Stern SL, et al.: Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999; 71: 209-213. (Pubitemid 29388015)
23. Korn EL, Liu PY, Lee SJ, et al.: Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol 2008; 26: 527-534. (Pubitemid 351264344)
24. Hodi FS, O'Day SJ, McDermott DF, et al.: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-723.
25. Flaherty KT, Puzanov I, Kim KB, et al.: Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363: 809-819.